ArticleBMC bioinformatics2026
Impact of influential data on screening epigenome-wide data.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundttScreening (TT) is an effective high-dimensional screening algorithm to identify important cytosine-phosphate-guanine dinucleotide (CpG) sites associated with DNA methylation. Via simulations, we aimed to examine the impact of influential outliers on TT’s performance.
methodsWe simulated K = 2,000 and 10,000 CpG sites across n = 100 and 200 subjects, linearly associated with a continuous outcome, [Formula: see text], and other latent variables with the error term following a normal or Cauchy distribution. Among the K CpGs, 10 were associated with [Formula: see text] (informative CpGs) while the remaining sites were not associated with [Formula: see text] (non-informative CpGs). We artificially created 1 to 5 influential points in one informative and one non-informative CpG site and compared TT’s accuracy to Bonferroni and false discovery rate (FDR)-based approaches.
resultsTT performed as well as or better than the FDR and Bonferroni-based approaches, across all degrees of influentiality. When focusing on non-informative CpG detection, regardless of sample size, all approaches had high accuracy (above 85%, overall) at their optimal cutoff for a single influential point. Among the CpG sites with a higher number of influential points (five points) and a normal error term, TT required a minimum cutoff of 70% for accuracy [Formula: see text] compared to FDR and Bonferroni, both of which had an accuracy of 0% for n = 100 and 200. However, increasing the TT cutoff to 80% increased accuracy to 20% and 24%, respectively, and further increased to 97% and 99% for a 90% cutoff, respectively (among K = 2000). We observed the same patterns for 10,000 CpGs and informative CpG detection. When Cauchy error terms were applied, the same patterns held, but with a higher magnitude of accuracy for all approaches, and thus TT required lower cutoffs to achieve 100% accuracy. In summary, in the presence of influential data, we recommend a more conservative cutoff of 70–90% compared to the default cutoff of 50–70% suggested by Ray et al. (in Biomed Res Int 2016(1):2615348, 2016).
conclusionTT, Bonferroni, and FDR are capable approaches for type 1 protection when screening high-dimensional data. However, in the presence of influential data, TT is likely to be the most robust approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.